Renal hemodynamics in essential hypertensives is characterized by an i
ncrease in renal vascular resistance (RVR) and a decrease in renal pla
sma flow (RPF), while glomerular filtration rate (GFR) is either norma
l or slightly decreased. Filtration fraction (FF) is increased, indica
ting that vasoconstriction predominantly affects postglomerular arteri
es. This increase in FF, called hyperfiltration, can be regarded as a
successful maintenance of a normal glomerular filtration but can be de
leterious for long-term renal function by favoring the development of
glomerulosclerosis. Administration of some beta-blockers (especially p
ropranolol) to hypertensive patients still reduces RPF and GFR, and in
creases FF. Conversely, in short-term studies, tertatolol has been sho
wn to reduce RVR and increase RPF, without altering FF in hypertensive
patients. These effects correspond to a normalization of the renal he
modynamic profile. Their practical interest is however strongly depend
ent on their persistance in long-term treatment. The beneficial effect
s of tertatolol were confirmed in 3 long-term studies, lasting for one
year. These three studies yielded remarkably similar results: there w
as a modest overall decrease in serum creatinine, and a more pronounce
d drop in patients whose pretreatment renal function was altered. Thes
e data suggest that tertatolol may preserve the long-term autoregulati
on of renal hemodynamics. The possibility is raised that in patients w
ith minimal renal dysfunction, tertatolol may also slow down the progr
ession of renal failure.